Atai Life Sciences and Cybin Announce Progress in Psychedelic Drug Studies
LOS ANGELES-- In a sector where every advancement is keenly ...
Medical Cannabis Push Gains Momentum in Idaho
IDAHO — The quest to introduce medical cannabis in Idaho ...
Cybin Inc. Successfully Completes Phase 2 Dosing of Promising Psilocybin Analog for Depression Treatment
NEW YORK — Cybin Inc., a psychedelic-based medical treatments, announced ...
Georgia Health Officials Miscount Medical Cannabis Patients, Affecting Dispensary Plans
ATLANTA — A recent revelation by the Georgia Department of ...
U.S. Targets Chinese Firms Over Fentanyl Production
WASHINGTON — In a firm response to the surge of ...
Cannabis Stocks Show Resurgence Amid Regulatory Optimism
NEW YORK- Cannabis stocks, as reflected by the Global Cannabis ...
California Cannabis Bills Await Governor’s Signature: Implications for Social Equity and Business
LOS ANGELES— A recent session saw California lawmakers passing multiple ...
MediPharm Settles $9 Million Dispute with HEXO Following Tilray’s Acquisition
TORONTO — The landscape of the Canadian cannabis industry experienced ...
U.S. Senate Banking Committee Advances SAFER Banking Act: A Look at the Stance and Votes
WASHINGTON — The U.S. Senate Banking Committee's anticipated markup of ...
Federal Judge Halts Arkansas Ban on Hemp-derived THC Products
LOS ANGELES- A significant judicial ruling in Arkansas has stalled ...
